Treatment of impaired muscles after cerebral effusion by voluntarily activated electric shocks

Effectiveness of the Brain Interface Associated Machine Functional Electrical Stimulation in Patients with Sequelae after AVE

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-4dnqys

Enrollment

Unknown

Registered

2019-06-05

Start date

2019-03-15

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequelae of stroke not specified as hemorrhagic or ischemic

Interventions

Experimental group: Group A: 20 individuals after stroke in chronic phase with paresis will undergo therapy with the Interface EMG-FES. Group B: 20 individuals after stroke in chronic phase with Plegi

Device

Behavioural

Other

F04.711.513.603

SP1.011.122

E01.370.376.300

E01.370.405.255

G11.427.565

Eligibility

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients post stroke at 6 months to 2 years after the injury who present motor deficit in the upper limb.

Exclusion criteria

Exclusion criteria: Patients with metallic implants in the limb to be treated or local hyposensitivity or allodynia. Disapproved in the Mini-mental test.

Design outcomes

Primary

Measure	Time frame
There will be cerebral neuroplasticity through the intervention of the EEG-FES and EMG-FES interfaces through the received stimuli and visual biofeedback	—

Secondary

Measure	Time frame
Patients will gain functional gains through therapy, maintaining movements after training time.	—

Countries

Brazil

Contacts

Public ContactEddy;Eddy Krueger;Krueger

Universidade Estadual de Londrina;Universidade Estadual de Londrina

ekrueger@uel.br;ekrueger@uel.br+55 043 96238999;043996238999

Outcome results

None listed

Source: REBEC (via WHO ICTRP)